Nathaniel B. Fernhoff

4.4k total citations · 2 hit papers
27 papers, 2.8k citations indexed

About

Nathaniel B. Fernhoff is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Nathaniel B. Fernhoff has authored 27 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Nathaniel B. Fernhoff's work include Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (7 papers) and CAR-T cell therapy research (6 papers). Nathaniel B. Fernhoff is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (7 papers) and CAR-T cell therapy research (6 papers). Nathaniel B. Fernhoff collaborates with scholars based in United States, India and Germany. Nathaniel B. Fernhoff's co-authors include Irving L. Weissman, Michael A. Marletta, Jennifer Zamanian, Melanie Hayden Gephart, Mariko L. Bennett, Edward F. Chang, Gerald A. Grant, Christopher J. Bohlen, F. Chris Bennett and Andrew F. Tucker and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nathaniel B. Fernhoff

26 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New tools for studying microglia in the mouse and human CNS

2016 1.3k citations Mariko L. Bennett, F. Chris Bennett et al. Proceedings of the National Academy of Sciences profile →
Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

2013 506 citations Jens-Peter Volkmer, John W. Fathman et al. Proceedings of the National Academy of Sciences profile →

Peers

Nathaniel B. Fernhoff

IMMUN

NEURO

PHYSI

ONCOL

Hai Ngu United States

Sagar Sagar Germany

Hoa Nguyen United States

Marta Joana Costa Jordão Germany

Felix J. Hartmann United States

Karolina Wosik Canada

Lyne Bourbonnière Canada

Ben W. Dulken United States

Bahareh Ajami United States

Hajime Yano Japan

Hai Ngu United States

Nathaniel B. Fernhoff

903 ×0.6

IMMUN

1.0k ×1.0

NEURO

1.2k ×1.6

635 ×1.1

PHYSI

329 ×0.9

ONCOL

Citations per year, relative to Nathaniel B. Fernhoff Nathaniel B. Fernhoff (= 1×) peers Hai Ngu

Countries citing papers authored by Nathaniel B. Fernhoff

Since Specialization

Citations

This map shows the geographic impact of Nathaniel B. Fernhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel B. Fernhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel B. Fernhoff more than expected).

Fields of papers citing papers by Nathaniel B. Fernhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel B. Fernhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel B. Fernhoff. The network helps show where Nathaniel B. Fernhoff may publish in the future.

Co-authorship network of co-authors of Nathaniel B. Fernhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel B. Fernhoff. A scholar is included among the top collaborators of Nathaniel B. Fernhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel B. Fernhoff. Nathaniel B. Fernhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salhotra, Amandeep, Mehrdad Abedi, Samer A. Srour, et al.. (2025). Preliminary Safety and Efficacy of Myeloablative Orca-Q with No GvHD Prophylaxis for Treatment of Advanced Hematologic Malignancies. Transplantation and Cellular Therapy. 31(2). S107–S107. 2 indexed citations

Srour, Samer A., Jeremy Pantin, Sagar S. Patel, et al.. (2024). AML-521 Treatment of Acute Myeloid Leukemia With Orca-T. Clinical Lymphoma Myeloma & Leukemia. 24. S317–S317. 1 indexed citations

Abedi, Mehrdad, Samer A. Srour, Amandeep Salhotra, et al.. (2024). Preliminary Safety and Efficacy of Myeloablative Orca-Q with No GvHD Prophylaxis for Treatment of Advanced Hematologic Malignancies. Blood. 144(Supplement 1). 382–382. 3 indexed citations

Srour, Samer A., Amandeep Salhotra, Robert Lowsky, et al.. (2023). CT-632 Orca-Q Demonstrates Favorable Graft-Versus-Host Disease (GvHD) and Relapse-Free Survival With Haploidentical Donors Without Post-Transplant Cyclophosphamide. Clinical Lymphoma Myeloma & Leukemia. 23. S537–S537. 1 indexed citations

Patel, Sagar S., Edmund K. Waller, Jeremy Pantin, et al.. (2023). High Disease-Free Survival in Patients with High-Risk MDS Treated with Orca-T. Blood. 142(Supplement 1). 2230–2230. 2 indexed citations

Srour, Samer A., Amandeep Salhotra, Robert Lowsky, et al.. (2023). Safety and Efficacy of Orca-Q with Haploidentical Donors for the Treatment of Advanced Hematologic Malignancies without the Use of Post-Transplant Cyclophosphamide. Blood. 142(Supplement 1). 773–773. 4 indexed citations

Oliai, Caspian, Jeremy Pantin, Lori Muffly, et al.. (2023). Optimizing Outcomes with Myeloablative Conditioning in Older Patients: Efficacy and Safety of Precision Engineered Orca-T in Patients > 55 Years Old with Hematologic Malignancies. Blood. 142(Supplement 1). 230–230. 2 indexed citations

Meyer, Everett, M. Scott Killian, Sean Summers, et al.. (2022). Rapid Immune Reconstitution and Elevated Regulatory T Cell Frequencies in Patients Treated with Orca-T. Blood. 140(Supplement 1). 7656–7657. 1 indexed citations

Meyer, Everett, Anna Pavlova, Caspian Oliai, et al.. (2022). CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22. S447–S447. 2 indexed citations

10.

Salhotra, Amandeep, Samer A. Srour, Ayman Saad, et al.. (2022). Orca-Q Demonstrates Favorable GvHD-and-Relapse-Free Survival in Haploidentical Transplants without Post-Transplant Cyclophosphamide. Blood. 140(Supplement 1). 1865–1866. 4 indexed citations

11.

Tsai, Jonathan M., Rahul Sinha, Jun Seita, et al.. (2018). Surgical adhesions in mice are derived from mesothelial cells and can be targeted by antibodies against mesothelial markers. Science Translational Medicine. 10(469). 91 indexed citations

12.

Rosental, Benyamin, Zhanna Kozhekbaeva, Nathaniel B. Fernhoff, Jonathan M. Tsai, & Nikki Traylor‐Knowles. (2017). Coral cell separation and isolation by fluorescence-activated cell sorting (FACS). BMC Cell Biology. 18(1). 30–30. 40 indexed citations

13.

Bennett, Mariko L., F. Chris Bennett, Shane A. Liddelow, et al.. (2016). New tools for studying microglia in the mouse and human CNS. Proceedings of the National Academy of Sciences. 113(12). E1738–46. 1298 indexed citations breakdown →

14.

Fathman, John W., Nathaniel B. Fernhoff, Jun Seita, et al.. (2014). Upregulation of CD11A on Hematopoietic Stem Cells Denotes the Loss of Long-Term Reconstitution Potential. Stem Cell Reports. 3(5). 707–715. 14 indexed citations

15.

Weiskopf, Kipp, Aaron M. Ring, Chia Chi M. Ho, et al.. (2013). Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies. Science. 341(6141). 88–91. 376 indexed citations

16.

Inlay, Matthew A., et al.. (2013). Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification. Chemical Communications. 49(43). 4971–4971. 35 indexed citations

17.

Fernhoff, Nathaniel B., Emily R. Derbyshire, Eric S. Underbakke, & Michael A. Marletta. (2012). Heme-assisted S-Nitrosation Desensitizes Ferric Soluble Guanylate Cyclase to Nitric Oxide. Journal of Biological Chemistry. 287(51). 43053–43062. 54 indexed citations

18.

Smith, Brian C., Nathaniel B. Fernhoff, & Michael A. Marletta. (2012). Mechanism and Kinetics of Inducible Nitric Oxide Synthase Auto-S-nitrosation and Inactivation. Biochemistry. 51(5). 1028–1040. 28 indexed citations

19.

Fernhoff, Nathaniel B., Emily R. Derbyshire, & Michael A. Marletta. (2009). A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase. Proceedings of the National Academy of Sciences. 106(51). 21602–21607. 111 indexed citations

20.

Mitchell, Douglas A., Sarah U. Morton, Nathaniel B. Fernhoff, & Michael A. Marletta. (2007). Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proceedings of the National Academy of Sciences. 104(28). 11609–11614. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact